Web 2.0 would have been unthinkable without JavaScript, a scripting language used mainly for DOM scripting in web browsers.
Free agent Jordan Henderson signs a two-year deal with Chelsea after his contract with Premier League rivals Brentford is ...
AI coding agents can accelerate development, but they may also generate bloated code and technical debt. Learn where they ...
HBO Max has launched two new AI-powered mobile features in the US, including HBO Max Shorts, a vertical scrollable feed of iconic clips from its library designed to help users discover new content, ...
NEW YORK – July 28, 2026 – Streaming usage appeared to begin its summer ascent in May as audiences’ time spent streaming increased to 48.6% of total TV watch-time (+1.0 pt.), according to Nielsen’s ...
Monday's news conference was the first opportunity to ask Xabi Alonso why he had not ended up managing his former club Liverpool. Alonso, who won an array of honours as a player at Liverpool, ...
Eli Lilly’s up-to-$2.3 billion acquisition of Ajax Therapeutics is facing its first major public test, and the initial clinical data show why the pharma giant made the bet. The Ajax acquisition was a ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
Trials of the British Army’s Ajax armoured vehicles are set to resume, despite major delays amid concern for soldiers’ safety. Minister for Defence Readiness and Industry Luke Pollard announced in ...
LONDON, April 28 (Reuters) - Britain's defence readiness minister Luke Pollard said he had agreed to restart the army's acceptance of Ajax armoured vehicles from General Dynamics with ‌strict controls ...
Eli Lilly LLY0.48%increase; up pointing triangle continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer ...
Eli Lilly (LLY) has agreed to acquire biopharmaceutical company Ajax Therapeutics for up to $2.3B in cash, inclusive of an upfront payment and subsequent payments upon the achievement of certain ...